Cargando…

Erratum: Virus-like particles are efficient tools for boosting mRNA-induced antibodies

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071270/ https://www.ncbi.nlm.nih.gov/pubmed/37025996 http://dx.doi.org/10.3389/fimmu.2023.1183189

Ejemplares similares

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates
por: Xiao, Peng, et al.
Publicado: (2021)

Influenza Viruses: Innate Immunity and mRNA Vaccines
por: Lee, SangJoon, et al.
Publicado: (2021)

Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023)

mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
por: Dowell, Alexander C., et al.
Publicado: (2022)

Pseudomonas mRNA 2.0: Boosting Gene Expression Through Enhanced mRNA Stability and Translational Efficiency
por: Neves, Dário, et al.
Publicado: (2020)

Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
por: Liu, Shaojun, et al.
Publicado: (2023)

ESCRT recruitment to mRNA-encoded SARS-CoV-2 spike induces virus-like particles and enhanced antibody responses
por: Hoffmann, Magnus A. G., et al.
Publicado: (2022)

Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol
por: Sablerolles, Roos S. G., et al.
Publicado: (2021)

Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients
por: Chu, Chang, et al.
Publicado: (2023)

mRNA vaccines for cancer immunotherapy
por: Vishweshwaraiah, Yashavantha L., et al.
Publicado: (2022)

Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice
por: Li, Xingxing, et al.
Publicado: (2023)

Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling
por: Lee, Frank Fang Yao, et al.
Publicado: (2022)

TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization
por: Chang, Xinyue, et al.
Publicado: (2022)

Modulation of mRNA 3′-End Processing and Transcription Termination in Virus-Infected Cells
por: Vijayakumar, Aarthi, et al.
Publicado: (2022)

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
por: Ladak, Reese Jalal, et al.
Publicado: (2022)

Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice
por: Kurtovic, Liriye, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies
por: Tada, Takuya, et al.
Publicado: (2022)

Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies
por: Lee, Jenny M., et al.
Publicado: (2023)

Advances in mRNA Vaccines for Infectious Diseases
por: Zhang, Cuiling, et al.
Publicado: (2019)

How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development
por: Duan, Qiongyu, et al.
Publicado: (2022)

Exploration of shared TF-miRNA‒mRNA and mRNA-RBP-pseudogene networks in type 2 diabetes mellitus and breast cancer
por: Tong, Wu, et al.
Publicado: (2022)

The Expression of Toll-Like Receptor 4 mRNA in PBMCs Is Upregulated in Smokers and Decreases Upon Smoking Cessation
por: Yeh, Hsin-Yu, et al.
Publicado: (2021)

A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques
por: Volkmann, Ariane, et al.
Publicado: (2022)

Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8(+) T Cell Responses but Differ in Capacity to Induce CD4(+) T Cell Responses and Antibody Responses
por: Pattinson, David J., et al.
Publicado: (2020)

ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
por: Hoffmann, Magnus A.G., et al.
Publicado: (2023)

Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy
por: Duan, Li-Juan, et al.
Publicado: (2022)

Screening for diagnostic targets in tuberculosis and study on its pathogenic mechanism based on mRNA sequencing technology and miRNA-mRNA-pathway regulatory network
por: Yang, Yue, et al.
Publicado: (2023)

COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads
por: Golan, Yarden, et al.
Publicado: (2021)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
por: Panova, Eugenia A., et al.
Publicado: (2023)

The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity
por: Tejedor Vaquero, Sonia, et al.
Publicado: (2021)

Long Lasting Cellular Immune Response Induced by mRNA Vaccination: Implication for Prevention Strategies
por: Vitiello, Laura, et al.
Publicado: (2022)

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2
por: Monzon-Posadas, Werner O., et al.
Publicado: (2023)

Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination
por: Hernández-Luis, Pablo, et al.
Publicado: (2022)

Analyses of circRNA and mRNA Profiles in Vogt–Koyanagi–Harada Disease
por: Shu, Jia, et al.
Publicado: (2021)

Advancing mRNA technologies for therapies and vaccines: An African context
por: Kairuz, Dylan, et al.
Publicado: (2022)

Amplifying mRNA vaccines: potential versatile magicians for oncotherapy
por: Hu, Chaoying, et al.
Publicado: (2023)

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
por: Gao, Yong, et al.
Publicado: (2018)

Attenuated Duck Hepatitis A Virus Infection Is Associated With High mRNA Maintenance in Duckling Liver via m6A Modification
por: Wu, Liping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u6ph5c9hnurrrh68l50kef2i2q